One Partner.
Concept to Commissioning.
Building a pharmaceutical manufacturing facility means managing dozens of disciplines simultaneously – architecture, process engineering, HVAC, cleanrooms, clean utilities, regulatory documentation, and inspection readiness. When these are handled by separate vendors with no unified accountability, the result is delays, cost overruns, and inspection failures. Pharmaco Global’s Turnkey model changes that. From feasibility study to final regulatory certification, you have one team responsible for every outcome, every timeline, and every deliverable. We don’t hand you off – we stay with you.
Two Pillars of Our Turnkey Offering
Our Turnkey solutions are built on two integrated service areas, each handled by specialist in-house teams:
Design and Engineering
GMP-compliant facility design across 102 documented engineering deliverables — covering architecture, HVAC, clean utilities, process, automation, and electrical. Compliance is engineered from day one, not retrofitted at inspection time.
Explore Design & Engineering →
Regulatory Services
End-to-end EU GMP certification guided by our in-house regulatory team — from gap analysis and eCTD dossier preparation to mock audits, QP submission, EU inspector liaison, and final certification. Unlock 44+ regulated export markets.
Explore Regulatory Services →Why Pharmaco Global for Turnkey?
Most pharma facility projects fail not because of one catastrophic mistake, but because of coordination gaps — between architect and HVAC engineer, between equipment supplier and regulatory team, between construction completion and inspection readiness. Pharmaco Global is built to close those gaps.
What Sets Us Apart
- Single point of accountability — one contract, one project manager, one escalation path from concept to commissioning
- GMP compliance engineered in at the design stage — not discovered at inspection
- Rare combination of in-house engineering AND in-house regulatory expertise under one roof
- 102-deliverable engineering framework across 19 design modules — fully documented, fully auditable
- Active international projects across 15+ countries including India, Saudi Arabia, UAE, Kazakhstan, Vietnam, Ethiopia, and the Philippines
- Progressive cost confidence — from ±15% at conceptual stage to ±10% at detailed design, so you commit Capex with clarity
Who We Work With
Our Turnkey clients include pharmaceutical manufacturers at every stage of growth — from companies building their first GMP facility to established exporters expanding into regulated international markets.

Oral Solid Dosage (OSD)

Injectables & Parenterals

Vaccines and Biologics

Oncology & Blood Plasma

Food Environment
Ready to Build Your Facility the Right Way?
Whether you are starting with an empty plot or upgrading an existing facility, Pharmaco Global brings the engineering expertise, regulatory intelligence, and project accountability to deliver the facility your product and your markets demand.
Request a ConsultationFAQ's
A pharmaceutical turnkey solution is an end-to-end project delivery model where a single partner manages facility design, cleanroom construction, HVAC, clean utilities, equipment supply, commissioning, and GMP certification. The client receives a fully operational, regulatory-compliant manufacturing plant — ready to start production — without coordinating multiple vendors across separate project phases.
EPC stands for Engineering, Procurement, and Construction — the three core phases of a pharmaceutical turnkey project. In practice, EPC and turnkey are often used interchangeably. A true pharmaceutical EPC turnkey contractor delivers all three phases in-house under a single contract, whereas a project broker subcontracts each phase and acts as an intermediary without direct execution capability.
A GMP-compliant pharmaceutical facility typically takes 18–36 months from concept to regulatory certification, depending on size, dosage form complexity, and target regulatory standard. Greenfield plants take longer; brownfield upgrades or modular solutions can compress timelines to 12–18 months. The critical path is usually GMP certification, not construction itself.
A pharmaceutical turnkey project moves through six stages: feasibility and site assessment, conceptual design, detailed engineering, construction and cleanroom build, equipment installation and commissioning, and qualification and validation (IQ/OQ/PQ). Regulatory filing and GMP inspection follow, culminating in a manufacturing licence and production-ready facility handed over to the client.
Choose a pharmaceutical turnkey solutions provider with proven in-house capability across design engineering, cleanroom construction, clean utilities, equipment supply, and regulatory certification — not just one discipline. Verify regulatory track record across FDA, EU GMP, WHO, and PIC/S inspections, request project references with similar facility types, and confirm single-contract accountability throughout the full project lifecycle.
Pharmaceutical manufacturing facilities must comply with the applicable GMP standard for their target market: WHO GMP for developing-market export, EU GMP for 44+ European-regulated markets, FDA 21 CFR Parts 210–211 for the US, and PIC/S GMP for mutual recognition markets. Facilities targeting multiple markets require design and documentation aligned with the most stringent applicable standard.
Pharmaceutical facility commissioning involves verifying that utilities, equipment, and systems are installed and operate as designed. Validation confirms performance under GMP conditions through Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). A turnkey provider delivers full commissioning and validation documentation packages aligned with FDA, EU GMP Annex 15, and WHO validation guidelines.
Multiple vendors create accountability gaps — design errors discovered during construction are disputed between the architect, engineer, and builder. A single pharmaceutical turnkey partner owns design, construction, and validation under one contract, eliminating interface risk, accelerating regulatory approval timelines, and ensuring GMP compliance is engineered in from concept rather than retrofitted after construction is complete.
